129 related articles for article (PubMed ID: 23054987)
1. Effects of processing on the release profiles of matrix systems containing 5-aminosalicylic acid.
Korbely A; Kelemen A; Kása P; Pintye-Hódi K
AAPS PharmSciTech; 2012 Dec; 13(4):1341-7. PubMed ID: 23054987
[TBL] [Abstract][Full Text] [Related]
2. Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.
Elbary AA; Aboelwafa AA; Al Sharabi IM
AAPS PharmSciTech; 2011 Dec; 12(4):1454-64. PubMed ID: 22038474
[TBL] [Abstract][Full Text] [Related]
3. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
Grund J; Koerber M; Walther M; Bodmeier R
Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
[TBL] [Abstract][Full Text] [Related]
5. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
Nguyen C; Christensen JM; Ayres JW
Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding.
Quinten T; Andrews GP; De Beer T; Saerens L; Bouquet W; Jones DS; Hornsby P; Remon JP; Vervaet C
AAPS PharmSciTech; 2012 Dec; 13(4):1197-211. PubMed ID: 22965662
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
Obeidat WM; Nokhodchi A; Alkhatib H
AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
Ma Y; Li WZ; Chen DW
Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
[TBL] [Abstract][Full Text] [Related]
9. The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.
Kubova K; Peček D; Hasserová K; Doležel P; Pavelková M; Vyslouzil J; Muselík J; Vetchy D
Pharm Dev Technol; 2017 Mar; 22(2):206-217. PubMed ID: 28058866
[TBL] [Abstract][Full Text] [Related]
10. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
11. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
Košir D; Ojsteršek T; Vrečer F
Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
[TBL] [Abstract][Full Text] [Related]
12. Dissolution stability studies of suspensions of prolonged-release diclofenac microcapsules prepared by the Wurster process: I. Eudragit-based formulation and possible drug-excipient interaction.
Adeyeye MC; Mwangi E; Katondo B; Jain A; Ichikawa H; Fukumori Y
J Microencapsul; 2005 Jun; 22(4):333-42. PubMed ID: 16214782
[TBL] [Abstract][Full Text] [Related]
13. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices.
Azarmi S; Farid J; Nokhodchi A; Bahari-Saravi SM; Valizadeh H
Int J Pharm; 2002 Oct; 246(1-2):171-7. PubMed ID: 12270619
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
[TBL] [Abstract][Full Text] [Related]
15. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of floating multi-layer coated tablets based on gas formation.
Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
[TBL] [Abstract][Full Text] [Related]
17. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
18. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
Wu C; McGinity JW
Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
[TBL] [Abstract][Full Text] [Related]
19. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
Speer I; Lenhart V; Preis M; Breitkreutz J
Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
[TBL] [Abstract][Full Text] [Related]
20. Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator.
Asada T; Yoshihara N; Ochiai Y; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 541(1-2):246-252. PubMed ID: 29496456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
